Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

RZLT Relative to the S&P 500

RZLT Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Rezolute, Inc. (NASD:RZLT) seasonal charts above shows that a Buy Date of November 12 and a Sell Date of January 31 has resulted in a geometric average return of 47.42% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 72.47% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

To download RZLT seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: RZLT